IBDEI0AX ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10932,2)
 ;;=^5006357
 ;;^UTILITY(U,$J,358.3,10933,0)
 ;;=H54.12^^53^604^2
 ;;^UTILITY(U,$J,358.3,10933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10933,1,3,0)
 ;;=3^Blindness-Left Eye/Low Vision-Right Eye
 ;;^UTILITY(U,$J,358.3,10933,1,4,0)
 ;;=4^H54.12
 ;;^UTILITY(U,$J,358.3,10933,2)
 ;;=^5006360
 ;;^UTILITY(U,$J,358.3,10934,0)
 ;;=H54.11^^53^604^5
 ;;^UTILITY(U,$J,358.3,10934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10934,1,3,0)
 ;;=3^Blindness-Right Eye/Low Vision-Left Eye
 ;;^UTILITY(U,$J,358.3,10934,1,4,0)
 ;;=4^H54.11
 ;;^UTILITY(U,$J,358.3,10934,2)
 ;;=^5006359
 ;;^UTILITY(U,$J,358.3,10935,0)
 ;;=H54.2^^53^604^8
 ;;^UTILITY(U,$J,358.3,10935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10935,1,3,0)
 ;;=3^Low Vision,Both Eyes
 ;;^UTILITY(U,$J,358.3,10935,1,4,0)
 ;;=4^H54.2
 ;;^UTILITY(U,$J,358.3,10935,2)
 ;;=^5006361
 ;;^UTILITY(U,$J,358.3,10936,0)
 ;;=H54.3^^53^604^9
 ;;^UTILITY(U,$J,358.3,10936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10936,1,3,0)
 ;;=3^Unqualified Visual Loss,Both Eyes
 ;;^UTILITY(U,$J,358.3,10936,1,4,0)
 ;;=4^H54.3
 ;;^UTILITY(U,$J,358.3,10936,2)
 ;;=^268886
 ;;^UTILITY(U,$J,358.3,10937,0)
 ;;=H54.41^^53^604^6
 ;;^UTILITY(U,$J,358.3,10937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10937,1,3,0)
 ;;=3^Blindness-Right Eye/Normal Vision-Left Eye
 ;;^UTILITY(U,$J,358.3,10937,1,4,0)
 ;;=4^H54.41
 ;;^UTILITY(U,$J,358.3,10937,2)
 ;;=^5006363
 ;;^UTILITY(U,$J,358.3,10938,0)
 ;;=H54.42^^53^604^3
 ;;^UTILITY(U,$J,358.3,10938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10938,1,3,0)
 ;;=3^Blindness-Left Eye/Normal Vision-Right Eye
 ;;^UTILITY(U,$J,358.3,10938,1,4,0)
 ;;=4^H54.42
 ;;^UTILITY(U,$J,358.3,10938,2)
 ;;=^5133518
 ;;^UTILITY(U,$J,358.3,10939,0)
 ;;=H54.7^^53^604^10
 ;;^UTILITY(U,$J,358.3,10939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10939,1,3,0)
 ;;=3^Visual Loss,Unspec
 ;;^UTILITY(U,$J,358.3,10939,1,4,0)
 ;;=4^H54.7
 ;;^UTILITY(U,$J,358.3,10939,2)
 ;;=^5006368
 ;;^UTILITY(U,$J,358.3,10940,0)
 ;;=H54.8^^53^604^7
 ;;^UTILITY(U,$J,358.3,10940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10940,1,3,0)
 ;;=3^Legal Blindness,as Defined in USA
 ;;^UTILITY(U,$J,358.3,10940,1,4,0)
 ;;=4^H54.8
 ;;^UTILITY(U,$J,358.3,10940,2)
 ;;=^5006369
 ;;^UTILITY(U,$J,358.3,10941,0)
 ;;=H54.10^^53^604^4
 ;;^UTILITY(U,$J,358.3,10941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10941,1,3,0)
 ;;=3^Blindness-One Eye/Low Vision-Other Eye,Unspec Eyes
 ;;^UTILITY(U,$J,358.3,10941,1,4,0)
 ;;=4^H54.10
 ;;^UTILITY(U,$J,358.3,10941,2)
 ;;=^5006358
 ;;^UTILITY(U,$J,358.3,10942,0)
 ;;=E11.9^^53^605^26
 ;;^UTILITY(U,$J,358.3,10942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10942,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,10942,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,10942,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,10943,0)
 ;;=E11.39^^53^605^15
 ;;^UTILITY(U,$J,358.3,10943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10943,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complications
 ;;^UTILITY(U,$J,358.3,10943,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,10943,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,10944,0)
 ;;=E11.36^^53^605^14
 ;;^UTILITY(U,$J,358.3,10944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10944,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Cataract
 ;;^UTILITY(U,$J,358.3,10944,1,4,0)
 ;;=4^E11.36
 ;;^UTILITY(U,$J,358.3,10944,2)
 ;;=^5002642
 ;;^UTILITY(U,$J,358.3,10945,0)
 ;;=E11.359^^53^605^20
 ;;^UTILITY(U,$J,358.3,10945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10945,1,3,0)
 ;;=3^DM Type 2 w/ Prolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10945,1,4,0)
 ;;=4^E11.359
 ;;^UTILITY(U,$J,358.3,10945,2)
 ;;=^5002641
 ;;^UTILITY(U,$J,358.3,10946,0)
 ;;=E11.351^^53^605^21
 ;;^UTILITY(U,$J,358.3,10946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10946,1,3,0)
 ;;=3^DM Type 2 w/ Prolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10946,1,4,0)
 ;;=4^E11.351
 ;;^UTILITY(U,$J,358.3,10946,2)
 ;;=^5002640
 ;;^UTILITY(U,$J,358.3,10947,0)
 ;;=E11.349^^53^605^22
 ;;^UTILITY(U,$J,358.3,10947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10947,1,3,0)
 ;;=3^DM Type 2 w/ Severe NonProlif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10947,1,4,0)
 ;;=4^E11.349
 ;;^UTILITY(U,$J,358.3,10947,2)
 ;;=^5002639
 ;;^UTILITY(U,$J,358.3,10948,0)
 ;;=E11.341^^53^605^23
 ;;^UTILITY(U,$J,358.3,10948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10948,1,3,0)
 ;;=3^DM Type 2 w/ Severe NonProlif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10948,1,4,0)
 ;;=4^E11.341
 ;;^UTILITY(U,$J,358.3,10948,2)
 ;;=^5002638
 ;;^UTILITY(U,$J,358.3,10949,0)
 ;;=E11.339^^53^605^18
 ;;^UTILITY(U,$J,358.3,10949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10949,1,3,0)
 ;;=3^DM Type 2 w/ Moderate NonProlif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10949,1,4,0)
 ;;=4^E11.339
 ;;^UTILITY(U,$J,358.3,10949,2)
 ;;=^5002637
 ;;^UTILITY(U,$J,358.3,10950,0)
 ;;=E11.331^^53^605^19
 ;;^UTILITY(U,$J,358.3,10950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10950,1,3,0)
 ;;=3^DM Type 2 w/ Moderate NonProlif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10950,1,4,0)
 ;;=4^E11.331
 ;;^UTILITY(U,$J,358.3,10950,2)
 ;;=^5002636
 ;;^UTILITY(U,$J,358.3,10951,0)
 ;;=E11.329^^53^605^16
 ;;^UTILITY(U,$J,358.3,10951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10951,1,3,0)
 ;;=3^DM Type 2 w/ Mild NonProlif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10951,1,4,0)
 ;;=4^E11.329
 ;;^UTILITY(U,$J,358.3,10951,2)
 ;;=^5002635
 ;;^UTILITY(U,$J,358.3,10952,0)
 ;;=E11.321^^53^605^17
 ;;^UTILITY(U,$J,358.3,10952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10952,1,3,0)
 ;;=3^DM Type 2 w/ Mild NonProlif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10952,1,4,0)
 ;;=4^E11.321
 ;;^UTILITY(U,$J,358.3,10952,2)
 ;;=^5002634
 ;;^UTILITY(U,$J,358.3,10953,0)
 ;;=E11.319^^53^605^24
 ;;^UTILITY(U,$J,358.3,10953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10953,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10953,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,10953,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,10954,0)
 ;;=E11.311^^53^605^25
 ;;^UTILITY(U,$J,358.3,10954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10954,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10954,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,10954,2)
 ;;=^5002632
 ;;^UTILITY(U,$J,358.3,10955,0)
 ;;=E10.9^^53^605^13
 ;;^UTILITY(U,$J,358.3,10955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10955,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,10955,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,10955,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,10956,0)
 ;;=E10.311^^53^605^11
 ;;^UTILITY(U,$J,358.3,10956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10956,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10956,1,4,0)
 ;;=4^E10.311
 ;;^UTILITY(U,$J,358.3,10956,2)
 ;;=^5002592
 ;;^UTILITY(U,$J,358.3,10957,0)
 ;;=E10.319^^53^605^12
 ;;^UTILITY(U,$J,358.3,10957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10957,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10957,1,4,0)
 ;;=4^E10.319
 ;;^UTILITY(U,$J,358.3,10957,2)
 ;;=^5002593
 ;;^UTILITY(U,$J,358.3,10958,0)
 ;;=E10.36^^53^605^1
 ;;^UTILITY(U,$J,358.3,10958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10958,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Cataract
 ;;^UTILITY(U,$J,358.3,10958,1,4,0)
 ;;=4^E10.36
 ;;^UTILITY(U,$J,358.3,10958,2)
 ;;=^5002602
 ;;^UTILITY(U,$J,358.3,10959,0)
 ;;=E10.39^^53^605^2
 ;;^UTILITY(U,$J,358.3,10959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10959,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Ophthalmic Complication
